Tag: Q3

November 10, 2016 Off

Comprehensive loss for Probiodrug in the third quarter of 2016

Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…

November 8, 2016 Off

Esperite's revenue slightly lifted in Q3 compared to same period last year

By Dino Mustafić

The Ducth pharmaceutical company Esperite N.V. has announced today that cumulative consolidated revenue increased